SciVision Biotech Past Earnings Performance

Past criteria checks 4/6

SciVision Biotech has been growing earnings at an average annual rate of 9.9%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 12.3% per year. SciVision Biotech's return on equity is 10.9%, and it has net margins of 25%.

Key information

9.9%

Earnings growth rate

8.8%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate12.3%
Return on equity10.9%
Net Margin25.0%
Next Earnings Update09 May 2024

Recent past performance updates

Recent updates

Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Apr 20
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Apr 02
SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Mar 15
Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Feb 25
Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Feb 05
Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Jan 18
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

Jan 01
Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Dec 14
SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Nov 25
Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Revenue & Expenses Breakdown
Beta

How SciVision Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TWSE:1786 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2371317825953
30 Sep 2367016824545
30 Jun 2362815921744
31 Mar 2357714818449
31 Dec 2255714218552
30 Sep 2253813817457
30 Jun 2250011216163
31 Mar 2249510415065
31 Dec 2150610215466
30 Sep 2149711214666
30 Jun 2149112614664
31 Mar 2146811614462
31 Dec 2046712813760
30 Sep 2046513314152
30 Jun 2044712413548
31 Mar 2044312712843
31 Dec 1943812112843
30 Sep 1941011210849
30 Jun 193801039948
31 Mar 19330818952
31 Dec 18330878848
30 Sep 18314738744
30 Jun 18296588443
31 Mar 18314559140
31 Dec 17258178239
30 Sep 17244217640
30 Jun 17251-287638
31 Mar 17231-286833
31 Dec 16228-266930
30 Sep 16218-377726
30 Jun 16238368624
31 Mar 16250419124
31 Dec 15265559125
30 Sep 15237229531
30 Jun 15197-58434
31 Mar 15181-97837
31 Dec 14158-227837
30 Sep 1417566632
30 Jun 14188266529
31 Mar 14194346326
31 Dec 13201405926
30 Sep 13226635428
30 Jun 13225655030

Quality Earnings: 1786 has high quality earnings.

Growing Profit Margin: 1786's current net profit margins (25%) are lower than last year (25.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1786's earnings have grown by 9.9% per year over the past 5 years.

Accelerating Growth: 1786's earnings growth over the past year (25.5%) exceeds its 5-year average (9.9% per year).

Earnings vs Industry: 1786 earnings growth over the past year (25.5%) exceeded the Medical Equipment industry -17.2%.


Return on Equity

High ROE: 1786's Return on Equity (10.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.